Katherine J Li1,2, Elske M Brouwer-Brolsma3, Charlotte Fleuti4, René Badertscher4, Guy Vergères4, Edith J M Feskens3, Kathryn J Burton-Pimentel4. 1. Division of Human Nutrition and Health, Department of Agrotechnology and Food Science, Wageningen University & Research, Wageningen, The Netherlands. katherinejia.li@agroscope.admin.ch. 2. Agroscope, Federal Department of Economic Affairs, Education and Research (EAER), Federal Office for Agriculture (FOAG), Bern, Switzerland. katherinejia.li@agroscope.admin.ch. 3. Division of Human Nutrition and Health, Department of Agrotechnology and Food Science, Wageningen University & Research, Wageningen, The Netherlands. 4. Agroscope, Federal Department of Economic Affairs, Education and Research (EAER), Federal Office for Agriculture (FOAG), Bern, Switzerland.
Abstract
PURPOSE: Milk-derived free fatty acids (FFAs) may act as both biomarkers of intake and metabolic effect. In this study we explored associations between different types of dairy consumption, a selection of milk-derived free fatty acids, and cardiometabolic disease (CMD) risk factors. METHODS: Sixty-seven FFAs were quantified in the plasma of 131 free-living Dutch adults (median 60 years) using gas chromatography-flame ionization detector. Intakes of different dairy foods and groups were assessed using a food frequency questionnaire. Twelve different CMD risk factors were analyzed. Multiple linear regressions were used to evaluate the associations under study. RESULTS: Based on the fully adjusted models, 5 long-chain unsaturated FFAs (C18:1 t13 + c6 + c7 + u, C18:2 c9t11 + u, C20:1 c11, C20:3 c8c11c14, and C20:4 c5c8c11c14), 2 medium-chain saturated FFAs (C15, C15 iso), and a trans FFA (C16:1 t9) were positively associated with at least one variable of dairy intake, as well as plasma total and LDL cholesterol, blood pressure, and SCORE (p ≤ 0.05). A long-chain PUFA associated with high-fat fermented dairy intake (C18:2 t9t12), was negatively associated with serum triglyceride levels, and a long-chain saturated FFA associated with cheese intake (C18:1 u1) was negatively associated with plasma LDL cholesterol and serum triglyceride levels. No clear associations were observed between dairy intake and CMD risk factors. CONCLUSION: Milk-derived FFAs could act as sensitive biomarkers for dairy intake and metabolism, allowing the association between dairy and CMD risk to be more precisely evaluated.
PURPOSE: Milk-derived free fatty acids (FFAs) may act as both biomarkers of intake and metabolic effect. In this study we explored associations between different types of dairy consumption, a selection of milk-derived free fatty acids, and cardiometabolic disease (CMD) risk factors. METHODS: Sixty-seven FFAs were quantified in the plasma of 131 free-living Dutch adults (median 60 years) using gas chromatography-flame ionization detector. Intakes of different dairy foods and groups were assessed using a food frequency questionnaire. Twelve different CMD risk factors were analyzed. Multiple linear regressions were used to evaluate the associations under study. RESULTS: Based on the fully adjusted models, 5 long-chain unsaturated FFAs (C18:1 t13 + c6 + c7 + u, C18:2 c9t11 + u, C20:1 c11, C20:3 c8c11c14, and C20:4 c5c8c11c14), 2 medium-chain saturated FFAs (C15, C15 iso), and a trans FFA (C16:1 t9) were positively associated with at least one variable of dairy intake, as well as plasma total and LDL cholesterol, blood pressure, and SCORE (p ≤ 0.05). A long-chain PUFA associated with high-fat fermented dairy intake (C18:2 t9t12), was negatively associated with serum triglyceride levels, and a long-chain saturated FFA associated with cheese intake (C18:1 u1) was negatively associated with plasma LDL cholesterol and serum triglyceride levels. No clear associations were observed between dairy intake and CMD risk factors. CONCLUSION: Milk-derived FFAs could act as sensitive biomarkers for dairy intake and metabolism, allowing the association between dairy and CMD risk to be more precisely evaluated.
Authors: Ivonne Sluijs; Nita G Forouhi; Joline W J Beulens; Yvonne T van der Schouw; Claudia Agnoli; Larraitz Arriola; Beverley Balkau; Aurelio Barricarte; Heiner Boeing; H Bas Bueno-de-Mesquita; Françoise Clavel-Chapelon; Francesca L Crowe; Blandine de Lauzon-Guillain; Dagmar Drogan; Paul W Franks; Diana Gavrila; Carlos Gonzalez; Jytte Halkjaer; Rudolf Kaaks; Aurelie Moskal; Peter Nilsson; Kim Overvad; Domenico Palli; Salvatore Panico; José R Quirós; Fulvio Ricceri; Sabina Rinaldi; Olov Rolandsson; Carlotta Sacerdote; María-José Sánchez; Nadia Slimani; Annemieke M W Spijkerman; Birgit Teucher; Anne Tjonneland; María-José Tormo; Rosario Tumino; Daphne L van der A; Stephen J Sharp; Claudia Langenberg; Edith J M Feskens; Elio Riboli; Nicholas J Wareham Journal: Am J Clin Nutr Date: 2012-07-03 Impact factor: 7.045
Authors: Sabita S Soedamah-Muthu; Lisa D M Verberne; Eric L Ding; Mariëlle F Engberink; Johanna M Geleijnse Journal: Hypertension Date: 2012-09-17 Impact factor: 10.190